Publications by authors named "Jaykumar Sejpal"

Claim this Profile
B
Biweekly DoceAqualip in mCRPC patients beyond 20 cycles: A case series.
Srikant Tiwari, Abhaya Bisaria, Harmeet Kaur, Nisarg Joshi, Jaykumar Sejpal

J Oncol Pharm Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in metastatic ovarian carcinoma: A retrospective study.
Sundaram Subramanian, Aseem Samar, Nisarg Joshi, Jaykumar Sejpal, Mujtaba A Khan

Mol Clin Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicentric, Retrospective Efficacy and Safety Study of Nanosomal Docetaxel Lipid Suspension in Metastatic Castration-Resistant Prostate Cancer.
Aseem Samar, Srikant Tiwari, Sundaram Subramanian, Nisarg Joshi, Jaykumar Sejpal

Prostate Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer.
Senthil Rajappa, Ashish Joshi, Dinesh C Doval, Ullas Batra, Rejiv Rajendranath, Jaykumar Sejpal

Oncol Lett· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis